АШУҮИС — Судалгааны мэдээлэл (CRIS)
Permanent URI for this communityhttps://library.mnums.edu.mn/handle/123456789/5001
Browse
11 results
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, The Potential Effect of Traditional Herbal Medicine on Bile Flow in CC14-Induced Liver Injury Model(Mongolian National University of Medical Sciences, 2024-09-27); ;Tuul Khalzaibaast; ; Chimedragchaa ChimedtserenObjective: To investigate whether the modified Mongolian traditional medicine Yaman Serdeg-3 (NYS-3) effects the biliary excretion in the carbon tetrachloride-induced liver injury model. Methods: Forty-seven male and female Sprague-Dawley rats were divided into 5 groups: Group I healthy group (n=12); Group II healthy group + NYS-3 (n=9); Group III liver injury model (n=10); Group IV liver injury model + Chinese medicine Hua gan Pian (n=10); Group V liver injury model + NYS-3. Experimental groups II-V, received corresponding medicinal preparations for 2 weeks. The dose of Hua gan Pian (HGP) was 0.046g/ml while the dose of NYS-3 was 2.025g/ml. For the acute induction of liver injury, the rats were orally administered 40% CCl4 in olive oil (4 ml/kg) twelve hours after the last administration of preparations. Results: At the first 15-minute interval, the highest bile flow was observed in Group II rats, which were administered NYS-3. This phenomenon continued at the second 15-minute interval, also. However, at the third 15-minute interval, the bile flow decreased sharply in Group II. On the other hand, in the liver injury model, untreated or pre-treated rats had significantly different bile flows. For example, in the first half of the experiment, both non-treated and HGP pre-treated groups had similar bile flow, while, the group pre-treated with NYS-3 had significantly low bile flow. Then, after 45 minutes of the experiment, the bile flow became similar amounts in both pre-treated groups. Conclusion: We conclude that the NYS-3 administration had increased the bile flow at 3rd 15min of interval, which is higher than positive control group where liver injury model rats received HGP. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The hyperplasia of the mammary gland effect of the Mongolian Remedy RuXian-I in rats reduced by estrogen and progesterone via inhibition of MAPK and NF-κB pathways(2024-04-28) ;Shuangquan Zhao ;Chimedragchaa Chimedtseren; ; Bin ZhangBackground: The aim of the present study was to evaluate whether the HMG (Hyperplasia of the Mammary Gland) effect of RuXian-I in estrogen- and progestogen- induced HMG rats is mediated through the activation of MAPK (Mitogen activated protein kinase) and NF-κB signaling pathways. Materials and methods: Fifty virgin female Wistar rats were randomly divided into in control and HMG, RuXian-I (0.75 g·kg−1, 1.5 g·kg−1, 3 g·kg−1, respectively) groups, 10 in each. Injections of estrogen and progestogen were given to establish rat models of HMG and RuXian-I at the same time. Changes in nipple heights were measured; pathologic changes of HMG in rats were also observed under a light microscope; the phosphorylation levels of MAPK and NF κB and the expression levels of TNF-α and IL-1β were measured. Results: Compared with the control group, the nipple diameters and height were increased significantly, the numbers of MG lobules were increased, there were changes in breast histopathology, the levels of TNF-α and IL-1β increased significantly, and MAPK and NF-κB were activated in HMG rats. Compared with the HMG model group, the increased nipple height was decreased, the numbers of MG lobules were reduced, the degree of HMG in rats was alleviated obviously, and the phosphorylation level of MAPK and NF-κB and cytokines TNF- α and IL-1β levels in serum were decreased by RuXian-I treatment. Conclusion: Those results suggest RuXian-I has protective and therapeutic effects on HMG rats induced by estrogen and progestogen and is likely to activate MAPK and NF-κB signaling pathways. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effect of Panzeria Alaschanica Kupr. on Carrageenan-Induced Acute Inflammation in Rats(Mongolian National University of Medical Sciences, 2023-09-30) ;Hu Bi Si Ha La Tu ;Khaliunaa Tumurbaatar ;Chimedragchaa Chimedtseren; Objectives: In the present study, we aimed to investigate the effect of Panzeria alaschanica Kupr. (P. alaschanica) on carrageenan-induced acute inflammation in rats. Method: Carrageenan-induced rat paw edema was used to evaluate the anti-inflammatory activity. P. alaschanica extract (32, 64, and 160 mg/kg/ BW) or vehicle was given orally 60 minutes before the subplantar injection of carrageenan. Ibuprofen (100 mg/kg) was used as a standard drug. The carrageenan-injected paw was measured 30, 60, 120, 180, and 240 minutes after the carrageenan injection. The levels of serum tumor necrosis factor (TNF)-α, interleukin (IL)-ELISA measured 1β, and IL-6. Results: The P. alaschanica at all given doses significantly (p˂0.01) inhibited carrageenan-induced rat paw edema. Moreover, it significantly reduced TNF-α, IL-1β, and IL-6 serum levels at different doses (p˂0.01). The anti-inflammatory effect of P. alaschanica was comparable to ibuprofen. Conclusion: P. alaschanica has an anti-inflammatory impact on carrageenan-induced paw edema in rats. The mechanism of action may partly be via reducing the levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Using Network Pharmacology to Clarify the Therapeutic Mechanism of Hataagqi-19 Hot Compress Therapy in Rats with Lumbar Disc Herniation(Mongolian National University of Medical Sciences, 2021-07-01) ;Aruhan ;Byambasuren Dorjsuren ;Chimedragchaa ChimedtserenObjective: This study aims to determine the primary efficacy of traditional medicine treatment of Lumbar disc herniation (LDH) and the effect of Hataagqi-19 hot compress (H19+HC) therapy on LDH rats. Methods: Referencing ancient books of Mongolian medicine, we studied the theoretical basis of Mongolian medicine to treat LDH. We performed operations to establish a model of SD rats with LDH treated with H19+HC. Paw withdrawal threshold (PWT) was detected, serum TNF-α, IL-6, and IL-1β were measured by ELISA, and immunohistochemical staining was used to measure IL-6, CD68, and IgG. Results: The medicinal properties of the drugs for the treatment of LDH are mainly dry “Xieriwusu,” heat-clearing, and suppressing “Heyi” medicine. The PWT value, serum TNF-α, IL-6, IL-1β and tissue IL-6, CD68, IgG of H19+HC was lower than that of the control group. The nucleus pulposus of the H19+HC was significantly smaller than that of the control group. The positive staining result in the main inflammatory cells of the lesion was CD68. Conclusions: Mongolian medicine treatment of LDH is based on the dry “Xieriwusu,” heat-clearing, and suppressing “Heyi” efficacy. The H19+HC therapy follows this efficacy and has the effects of improved abnormal behavior, analgesic, anti-inflammatory, and reabsorption of the nucleus pulposus. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effect of Erdene urel on Microglia / Macrophage Distribution and Inhibition of Inflammatory Response after Brain Ischemia in Rats(Mongolian National University of Medical Sciences, 2020-04-01) ;Hu Yu Rong ;Khaliunaa Tumurbaatar ;B. Gansukh; Chimedragchaa ChimedtserenObjectives: We studied the effect of Erdene urel on microglia/macrophage M1/M2 distribution and neuroinflammation using a cerebral ischemia-reperfusion injury model in rats. Methods: The middle cerebral artery occluded by thread occlusion, followed by reperfusion at 90 minutes after ischemia. The injury was studied at 1, 3, and 7 days after brain ischemia, and the neurological score was graded, after that, the brain tissue was collected by decollation. The phenotypes of M1 and M2 were detected by Iba1 and Arg-1 immunofluorescence, and the expressions of (TNF-D), (IL-1E), (IL-6), and (IL-10) were detected by ELISA. Result: The immunofluorescence showed that compared with the sham-operated group, the microglia/ macrophage (Iba1) in the ischemic area of the control group’s rats with middle cerebral artery occlusion and to which reperfusion was performed for 1, 3 and 7 days was increased (p<.05) and the number of M2 (Arg-1) (p<.05) was reduced. One day after reperfusion, the Erdene urel and nimodipine groups did not differ from the control group. However, after 3 and 7 days, the microglia/macrophage (Iba1) (p<.05) in the ischemic area of Erdene urel and nimodipine groups was reduced, while M2 (Arg-1) (p<.05) was increased. Conclusion: Erdene urel is likely capable of promoting the transformation of activated microglia/macrophages from M1 to M2. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Study on Preparation Technology and Safety Evaluation of Hataagqi-19 Hydrogel Patch(Mongolian National University of Medical Sciences, 2021-12-31) ;Aruhan ;Byambasuren Dorjsuren ;Xiaoling Song ;Chimedragchaa ChimedtserenMinhui LiObjectives: The study objective of the present study was to screen the dosage of matrix material and clarify the safety evaluation of Hataagqi-19 hydrogel patch. Methods: Single factor and orthogonal experiments were used to screen, and the best matrix ratio was screened out with peel strength, peel ability, viscosity, spread ability, uniformity, as evaluation indicators. Long term toxicity test was carried out in SD rats in order to test general conditions such as: body weight, food intake, electrocardiogram, blood, urine, and biochemical indicators, organ coefficients and histopathological changes. Moreover, skin allergic reaction tests were done to observe the allergic responce. Results: The ratio of the gel patch matrix is NP-700: aluminum glycolate: glycerol: carbomer = 6: 0.35: 35: 0.40; the ratio of azone and propylene glycol is 1: 1, and the total penetration enhancer dosage is 5%. Hataagqi-19 preparation had no obvious long-term toxicity or skin allergies. Conclusions: The Hataagqi-19 hydrogel patch prepared with the best ratio and transdermal agent showed good performance and safety. Furthermore, we did not observed toxic side effects, and the preparation process is feasible and reliable. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Hepatoprotective Activity of the Traditional Multicomponent Formulation Gurgem-13 on Carbon Tetrachloride (CCL4) Induced Experimental Liver Injury in Rats(Mongolian National University of Medical Sciences, 2019-12-29); ;Chimedragchaa Chimedtseren; Altantsetseg AltangerelObjectives: The purpose of present study was intended to evaluate hepatoprotective effects of traditional multicomponent formulation Gurgum13 on carbon tetrachloride (CCI4) induced liver injury model in rats. Methods: Chronic toxic liver injury was induced experimentally by intraperitoneal injection (IP) of 1.0 ml/kg body weight of 10% carbon tetrachloride (CCI4) three times per week for duration of three months in rats. A total of five groups of animals with 15 rats in each were used for the experiment. Group 1 was as a normal control (intact). Group 2 served as a control group received CCI4 1.0 ml/kg IP three times a week for 3 months. Group 3, 4 and 5 were as the treatment groups received CCI4 1 ml/kg IP and administered traditional multicomponent formulation Gurgum-13 as a test drug (100 mg/kg) for 3 months daily. Milk thistle (50 mg/kg) and Lilicoaguliant (LLC) (100 mg/kg) were given daily for 3 months as a reference drug respectively. The activity of Gurgum-13 formulation and other comparative drugs were investigated with the dynamic study of liver marker enzymes, AST, ALT, ALP, bilirubin, and the antioxidant and blood coagulating effects of the remedy, which were studied in three months of experimentation. Gurgum-13 is one of the Mongolian traditional multicomponent formulation used in practice for a range of diseases including liver disorders. Results: Carbon tetrachloride significantly decreased the liver functions as assessed through an increase in blood serum and liver marker enzymes in control groups. Gurgum-13 treatment significantly prevented hepatotoxicity of carbon tetrachloride by reducing ALT, AST, ALP marker enzymes and bilirubin in blood serum and liver tissue in the three months period of chronic hepatitis (p<.05) similar to reference drugs. The result of the study revealed that Gurgum-13 is significant hepatoprotective against liver injury from CCI4 induced hepatotoxicity by having antioxidant effect and decreasing lipid peroxidation in liver. Conclusion: Multicomponent traditional formulation Gurgum-13 demonstrated very good hepatoprotective effect against CCI4 induced liver injury in rats. Thus, Gurgum-13 can be an effective remedy for the treatment of chronic hepatitis and biliary tract disorders. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effect of Musk on Neurons in the Pattern of Ischemic Stroke(Mongolian National University of Medical Sciences, 2020-06-25); ; ;Dagvatseren Begzsuren ;Bat-Erdene JargalsaikhanObjectives: In this study, we investigated the neuroprotective effect of musk1 after brain ischemia in rats. Methods: The middle cerebral artery occlusion model in rats was established by thread occlusion and reperfusion was performed 90 minutes after ischemia. The reperfusion was performed separately on the first, third, and seventh day of the week after brain ischemia. The ischemia area was detected and the expressions of Arg-1, BCL-2, and lba-1 were detected by immunofluorescence staining. Results: The result of immunofluorescence showed that treatment with musk 50 mg/kg and 100 mg/kg for the first, third, and seventh days significantly improved the neurological function and increased the protein expression of Arg-1 and BCL-2 in the ischemic hemisphere of brains in rats. Also, the ischemic area was reduced. Conclusions: The research results confirms that Mongolian Badanga2 musk in 100 mg/kg doses, has functions of protecting neuro cells, supporting neurogenesis against inflammation, improving neuro tissues regeneration, and reducing ischemic areas through increasing brain tissues Arg-1 and BCL-2 protein's expressions, and reducing lba-1 proteins expressions. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Traditional Mongolian medicine RuXian-1 suppress the breast hyperplasia by GRP78/PERK/CHOP pathway in rat model(2024-08-30) ;Shuangquan Zhao ;Chimedragchaa Chimedtseren; In this study we aimed to study the protective effect of RuXian-1, which is a traditional Mongolian medicine on hyperplasia of mammary glands in rats and to explore its possible mechanism. Methods: The rat model of breast hyperplasia was induced by intramuscular injection of estradiol benzoate. The rats were randomly divided into 4 groups: saline treatment group (negative control), estrogen treatment group (model group), RuXian-1 treatment group and raloxifene treatment group (positive control). RuXian-1 group and raloxifene group were given 3.0 g/kg of RuXian-1 and 1.8 mg/kg of raloxifene daily for 4 weeks, respectively. After treatment, the breast tissue of each group was harvested and confirmed the expressions levels of glucose-related protein 78 (GRP78), C/EBP homologous protein (CHOP), and protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) which were known that functions as an endoplasmic reticulum stress marker by Western blotting. Results: Compared with the normal group, the GRP78, PERK and CHOP protein levels in the breast tissue of the model group were significantly decreased. Compared with the model group, the expression of GRP78, PERK and CHOP in RuXian-1 group significantly increased, the expression of GRP78 and CHOP of raloxifene significantly increased (p < 0.05), and the expression of PERK did not change. Conclusion: The Mongolian medicine RuXian-1 has therapeutic effect on mammary hyperplasia in rats, and its therapeutic mechanism is related to activating the GRP78/PERK/CHOP signaling pathway and promoting mammary gland cell apoptosis.Scopus© Citations 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effect of Astragalus Mongholicus Bunge Extract on Isoproterenol-Induced Myocardial Infarction in Rats(Mongolian National University of Medical Sciences, 2020-09-25); ;Anu Altangerel ;Yan Zhang ;B. GansukhObjectives: Our study’s objective was to investigate the cardioprotective effects of Astragalus mongholicus Bunge, a herbal medicine cultivated in Mongolia. Methods: Fifty rats were divided into five groups of ten. The untreated control and treatment group rats received isoproterenol (150 mg/kg) by subcutaneous injection for two consecutive days on 29th and 30th days to induce myocardial infarction. The treatment groups received Astragalus mongholicus Bunge 71, 142, or 284 mg/kg for 28 days prior to infarction. At the end of the experiment, Astragalus mongholicus Bunge’s cardioprotective effect was assessed through histopathology, the measurement of serum CK, AST, ALT, and LDH, and the oxidative stress markers malondialdehyde and total superoxide dismutase. Results: Treatment with Astragalus mongholicus Bunge 71 mg/kg caused significant decreases in the levels of LDH, AST, and CK serum compared with the control group (p < 0.05). Treatment with Astragalus mongholicus Bunge at 71, 142, and 284 mg/kg showed a significant decrease in malondialdehyde compared with the control group (p < 0.05). Treatment with Astragalus mongholicus Bunge at the same levels significantly reduced myocardial damage by protecting levels of the beneficial antioxidant enzyme total superoxide dismutase (p < 0.05). Histopathological examination of the group treated with Astragalus mongholicus Bunge 142 mg/kg showed a decreased area with necrosis and inflammatory cells in the myocardial tissue. Conclusion: The protective effect of Astragalus mongholicus Bunge occurs by protecting the myocardium’s native superoxide dismutase levels, reducing the levels of malondialdehyde and serum marker enzymes LDH, AST, and CK.
